EHealth Capex To Revenue from 2010 to 2024

EHTH Stock  USD 5.00  0.05  1.01%   
EHealth's Capex To Revenue is decreasing with very volatile movements from year to year. Capex To Revenue is estimated to finish at 0.02 this year. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.02380148
Current Value
0.024
Quarterly Volatility
0.01143437
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.9 M, Interest Expense of 11.5 M or Selling General Administrative of 46.8 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0116 or PTB Ratio of 0.26. EHealth financial statements analysis is a perfect complement when working with EHealth Valuation or Volatility modules.
  
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

Latest EHealth's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of eHealth over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. EHealth's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EHealth's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Very volatile
   Capex To Revenue   
       Timeline  

EHealth Capex To Revenue Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.03
Coefficient Of Variation35.49
Mean Deviation0.01
Median0.03
Standard Deviation0.01
Sample Variance0.0001
Range0.0366
R-Value(0.07)
Mean Square Error0.0001
R-Squared0
Significance0.82
Slope(0.0002)
Total Sum of Squares0

EHealth Capex To Revenue History

2024 0.024
2023 0.0238
2022 0.0383
2021 0.0388
2020 0.0408
2019 0.0333
2018 0.0431

About EHealth Financial Statements

Investors use fundamental indicators, such as EHealth's Capex To Revenue, to determine how well the company is positioned to perform in the future. Although EHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Capex To Revenue 0.02  0.02 

Currently Active Assets on Macroaxis

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.108
Earnings Share
(2.62)
Revenue Per Share
16.016
Quarterly Revenue Growth
(0.1)
Return On Assets
(0.01)
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.